Drug Shortage Report for TARO-ZOLEDRONIC ACID
| Report ID | 166405 |
| Drug Identification Number | 02415100 |
| Brand name | TARO-ZOLEDRONIC ACID |
| Common or Proper name | ZOLEDRONIC |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-08-09 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2024-07-01 |
| Shortage status | Resolved |
| Updated date | 2025-01-21 |
| Company comments | Recall with no back up inventory currently available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.